HK1219113A1 - Serum-free and insulin-free seventh factor production method - Google Patents

Serum-free and insulin-free seventh factor production method Download PDF

Info

Publication number
HK1219113A1
HK1219113A1 HK16106839.4A HK16106839A HK1219113A1 HK 1219113 A1 HK1219113 A1 HK 1219113A1 HK 16106839 A HK16106839 A HK 16106839A HK 1219113 A1 HK1219113 A1 HK 1219113A1
Authority
HK
Hong Kong
Prior art keywords
insulin
free
media
serum
cells
Prior art date
Application number
HK16106839.4A
Other languages
English (en)
Chinese (zh)
Inventor
Simone Von Fircks
Ruth Elmer
Manfred Dr. Reiter
Original Assignee
Baxalta Incorporated
Baxalta GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42165541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1219113(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxalta Incorporated, Baxalta GmbH filed Critical Baxalta Incorporated
Publication of HK1219113A1 publication Critical patent/HK1219113A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16106839.4A 2008-11-12 2016-06-14 Serum-free and insulin-free seventh factor production method HK1219113A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11379208P 2008-11-12 2008-11-12
US113792P 2008-11-12

Publications (1)

Publication Number Publication Date
HK1219113A1 true HK1219113A1 (en) 2017-03-24

Family

ID=42165541

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16106839.4A HK1219113A1 (en) 2008-11-12 2016-06-14 Serum-free and insulin-free seventh factor production method

Country Status (15)

Country Link
US (1) US20100120093A1 (https=)
EP (2) EP2356247B2 (https=)
JP (1) JP5719301B2 (https=)
AU (1) AU2009314345B2 (https=)
CA (1) CA2742107A1 (https=)
DK (1) DK2356247T4 (https=)
ES (1) ES2547881T5 (https=)
HK (1) HK1219113A1 (https=)
HR (1) HRP20151054T4 (https=)
HU (1) HUE026210T2 (https=)
IL (1) IL212355A (https=)
PL (1) PL2356247T5 (https=)
PT (1) PT2356247E (https=)
SI (1) SI2356247T2 (https=)
WO (1) WO2010056584A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013535981A (ja) * 2010-08-20 2013-09-19 ワイス・エルエルシー 成長因子不含適合細胞の細胞培養
US20120076779A1 (en) 2010-09-17 2012-03-29 Baxter Healthcare S.A. STABILIZATION OF IMMUNOGLOBULINS AND OTHER PROTEINS THROUGH AQUEOUS FORMULATIONS WITH SODIUM CHLORIDE AT WEAK ACIDIC TO NEUTRAL ph
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
KR20150026024A (ko) * 2013-08-30 2015-03-11 한미약품 주식회사 인간 혈액응고 7인자 유도체의 대량 생산 방법
US11286292B2 (en) 2014-02-07 2022-03-29 Cmc Biologics A/S Bioreactor arrangement and continuous process for producing and capturing a biopolymer
NZ724826A (en) * 2014-04-16 2022-07-29 Cmc Biologics As A high cell density fill and draw fermentation process
AU2015269365A1 (en) 2014-06-04 2016-12-15 Amgen Inc. Methods for harvesting mammalian cell cultures
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456591A (en) 1981-06-25 1984-06-26 Baxter Travenol Laboratories, Inc. Therapeutic method for activating factor VII
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
US5997864A (en) 1995-06-07 1999-12-07 Novo Nordisk A/S Modified factor VII
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
AT407255B (de) * 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
AT409379B (de) † 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
DK1200561T3 (da) † 1999-08-05 2006-10-16 Baxter Ag Rekombinant stabil celleklon, dens fremstilling og anvendelse
US20030204338A1 (en) 2002-04-22 2003-10-30 Peter Martinek Method and measurement probe for the performance of measurements in water supply systems
US20040185535A1 (en) † 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
BR0114373A (pt) * 2000-10-02 2004-02-17 Novo Nordisk As Célula hospedeira eucariótica, métodos para a produção de fvii e de fviia ou de suas variantes, de uma proteìna dependente de vitamina k e de uma célula hospedeira eucariótica produtora de fvii ou de seu análogo, vetor recombinante, fvii e fviia recombinante ou suas variantes, e, proteìna dependente de vitamina k recombinante
EP1434857B1 (en) * 2001-10-02 2007-08-01 Novo Nordisk Health Care AG Method for production of recombinant proteins in eukaryote cells
US20050214289A1 (en) * 2004-03-26 2005-09-29 Human Genome Sciences, Inc. Antibodies against Nogo receptor
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
EP1851305B1 (en) * 2005-02-11 2012-01-18 Novo Nordisk Health Care AG Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate
CN101300342A (zh) † 2005-11-02 2008-11-05 惠氏公司 用于使哺乳动物细胞具备适应性的方法
ES2474573T3 (es) † 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos

Also Published As

Publication number Publication date
PL2356247T5 (pl) 2019-10-31
SI2356247T1 (sl) 2015-11-30
PT2356247E (pt) 2015-10-26
CA2742107A1 (en) 2010-05-20
EP2977461A1 (en) 2016-01-27
JP2012508562A (ja) 2012-04-12
IL212355A0 (en) 2011-06-30
US20100120093A1 (en) 2010-05-13
JP5719301B2 (ja) 2015-05-13
ES2547881T5 (es) 2019-10-16
AU2009314345B2 (en) 2015-02-12
EP2356247A4 (en) 2013-01-02
PL2356247T3 (pl) 2016-04-29
WO2010056584A1 (en) 2010-05-20
SI2356247T2 (sl) 2019-08-30
EP2356247A1 (en) 2011-08-17
IL212355A (en) 2016-04-21
HRP20151054T4 (hr) 2019-11-15
EP2356247B2 (en) 2019-05-15
EP2356247B1 (en) 2015-07-15
HRP20151054T1 (xx) 2015-11-20
HUE026210T2 (en) 2016-05-30
ES2547881T3 (es) 2015-10-09
AU2009314345A1 (en) 2011-06-30
DK2356247T3 (en) 2015-09-21
DK2356247T4 (da) 2019-06-03

Similar Documents

Publication Publication Date Title
EP2356247B1 (en) Method of producing serum-free insulin-free factor vii
Avgerinos et al. Spin filter perfusion system for high density cell culture: production of recombinant urinary type plasminogen activator in CHO cells
WO2002029084A2 (en) Industrial-scale serum-free production of recombinant factor vii in mammalian cells
US20090263866A1 (en) Industrial-scale Serum-free Production of Recombinant Factor VII in Mammalian Cells
EP2235197B1 (en) Cell culture processes
EP1434857B1 (en) Method for production of recombinant proteins in eukaryote cells
KR102568951B1 (ko) 포유류 세포의 배양 방법
JP2007508003A (ja) 真核生物細胞におけるポリペプチドの大規模生産方法及びそれに適した培養容器
Hu et al. Pilot production of u-PA with porous microcarrier cell culture
KR20230170728A (ko) 포유류 세포의 관류 배양 방법
US20090075331A1 (en) Industrial-scale serum-free production of recombinant proteins in mammalian cells
US20210214702A1 (en) Process for production of recombinant tnk-tpa by packed-bed perfusion system
Jo et al. Performance study of perfusion cultures for the production of single-chain urokinase-type plasminogen activator (scu-PA) in a 2.5 l spin-filter bioreactor
Khaparde et al. Session: Biological Engineering ChemCon’04 Mumbai
HK1184500B (en) Cell culture processes